Skip to content

Research on New Prevention and Treatment Technology of Atrial Fibrillation and Stroke (efficacy and safety of catheter ablation for atrial fibrillation guided by noninvasive three-dimensional electrocardiographic mapping: a randomized controlled trial)

Efficacy and safety of catheter ablation for atrial fibrillation guided by noninvasive three-dimensional electrocardiographic mapping: a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900025576
Enrollment
Unknown
Registered
2019-09-02
Start date
2019-09-03
Completion date
Unknown
Last updated
2019-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Interventions

Sponsors

First Affiliated Hospital of Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with paroxysmal and persistent atrial fibrillation; 2. Patients aged between 18 and 80 years old; 3. Patients undergoing atrial fibrillation radiofrequency catheter ablation; 4. Informed consent can be obtained.

Exclusion criteria

Exclusion criteria: 1. Long-standing persistent or permanent atrial fibrillation; 2. Combined with other malignant arrhythmia such as sustained ventricular tachycardia; 3. Blood clots in the heart; 4. NYHA cardiac functional grading >=level III; 5. Other severe cardiac dysfunction, cardiac ion channel diseases, inherited arrhythmogenic diseases and so on; 6. Complicated with other severe diseases (e.g. hepatic and renal dysfunction, malignant tumor); 7. Pregnancy or be allergic to iodine contrast medium.

Design outcomes

Primary

MeasureTime frame
successful rate;total procedure time;whole fluoroscopic exposure;complication;

Countries

China

Contacts

Public ContactWei Mao

First Affiliated Hospital of Zhejiang Chinese Medical University

maoweilw@163.com+8615158190118

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026